115492 ⎘
Glycosyltransferases (2.4); Pentosyltransferases (2.4.2) NAD(+)--diphthamide ADP-ribosyltransferase (2.4.2.36)
ANTl-CMPL DIVALENT SCFV AND USES THEREOF
#2CHOLIX TOXIN-DERIVED FUSION MOLECULES FOR ORAL DELIVERY OF BIOLOGICALLY ACTIVE CARGO
#3CHIMERIC IL-10/CARRIER CONSTRUCTS FOR TREATMENT OF POUCHITIS AND METHODS OF USE
#4IL3Ra Antibody Conjugates and Uses Thereof
#5MHC CLASS I EPITOPE DELIVERING POLYPEPTIDES
#6DE-IMMUNIZED SHIGA TOXIN A SUBUNIT EFFECTOR POLYPEPTIDES FOR APPLICATIONS IN MAMMALS
#7CHOLIX TOXIN-DERIVED FUSION MOLECULES FOR ORAL DELIVERY OF BIOLOGICALLY ACTIVE CARGO
#8CHOLIX TOXIN-DERIVED FUSION MOLECULES FOR ORAL DELIVERY OF BIOLOGICALLY ACTIVE CARGO
#9CHOLIX TOXIN-DERIVED FUSION MOLECULES FOR ORAL DELIVERY OF BIOLOGICALLY ACTIVE CARGO
#10RECOMBINANT BACTERIUM AND USES THEREOF
#11MODIFIED EXOTOXIN A PROTEINS
#12MHC class I epitope delivering polypeptides
#13De-immunized Shiga toxin a subunit effector polypeptides for applications in mammals
#14C3 FUSION PROTEIN AND METHODS OF MAKING AND USING THEREOF
#15CHOLIX TOXIN-DERIVED FUSION MOLECULES FOR ORAL DELIVERY OF BIOLOGICALLY ACTIVE CARGO
#16MOLECULAR SIGNATURE OF CANCER
#17Methods of treating or preventing cancer with an agent that depletes tregs and a checkpoint inhibitor
#18IL3Ralpha antibodies and uses thereof
#19MHC class I epitope delivering polypeptides
#20Cholix toxin-derived fusion molecules for oral delivery of biologically active cargo
#21CHOLIX TOXIN-DERIVED FUSION MOLECULES FOR ORAL DELIVERY OF BIOLOGICALLY ACTIVE CARGO
#22C3 fusion protein and methods of making and using thereof
#23Functionalized DNA Dendrimers For Gene Delivery To Cells
#24CELL-TARGETING MOLECULES COMPRISING PROTEASE-CLEAVAGE RESISTANT, SHIGA TOXIN A SUBUNIT EFFECTOR POLYPEPTIDES AND CARBOXY-TERMINAL MOIETIES
#25Cholix toxin-derived fusion molecules for oral delivery of biologically active cargo
#26Compositions and methods for oral delivery of therapeutic cargo
#27Antibody-drug conjugates and the use of same in therapy
#28EXPRESSION SYSTEM
#29IL3Ralpha antibody conjugates and uses thereof
#30MHC Class I Epitope Delivering Polypeptides
#31Cholix toxin-derived fusion molecules for oral delivery of biologically active cargo
#32Cholix toxin-derived fusion molecules for oral delivery of biologically active cargo
#33Cholix toxin-derived fusion molecules for oral delivery of biologically active cargo
#34Cholix toxin-derived fusion molecules for oral delivery of biologically active cargo
#35IL3Rα antibody conjugates and uses thereof
#36Immunogenic compositions and reagents for preparing
#37Deimmunized therapeutic compositions and methods
#38EXPRESSION SYSTEM
#39Molecular signature of cancer
#40Fusion polypeptide for immuno-enhancement and method for enhancing stimulation of immune response using the same
#41Dosing strategies for targeting EPCAM positive bladder cancer
#42MOLECULAR SENSORS
#43AN IMMUNOTOXIN FOR USE IN THE TREATMENT OF LEISHMANIASIS
#44Ubiquitination system and the uses thereof
#45Cholix toxin-derived fusion molecules for oral delivery of biologically active cargo
#46POROUS NANOPARTICLE-SUPPORTED LIPID BILAYERS (PROTOCELLS) FOR TARGETED DELIVERY INCLUDING TRANSDERMAL DELIVERY OF CARGO AND METHODS THEREOF
#47Functionalized DNA Dendrimers For Gene Delivery To Cells
#48LYMPHOCYTE MEDIATED DELIVERY OF PROTEINS
#49IL3Rα antibody conjugates and uses thereof
#50Cholix toxin-derived fusion molecules for oral delivery of biologically active cargo
#51Human monoclonal antibodies specific for CD22
#52METHODS AND COMPOSITIONS FOR BI-SPECIFIC TARGETING OF CD19/CD22
#53Expression system
#54COMPOSITIONS AND METHODS FOR TREATING CANCER
#55Methods and compositions for modulating immune tolerance
#56Cell-targeting molecules comprising protease-cleavage resistant, Shiga toxin A subunit effector polypeptides and carboxy-terminal moieties
#57Targeting of chondroitin sulfate glycans
#58Covalently linked polypeptide toxin-antibody conjugates
#59Chimeric protein toxins for expression by therapeutic bacteria
#60Modified forms of exotoxin A
#61Fusion proteins for use as immunogenic enhancers for inducing antigen-specific T cell responses
#62Targeting of chondroitin sulfate glycans
#63MHC CLASS I EPITOPE DELIVERING POLYPEPTIDES AND CELL-TARGETED MOLECULES FOR DIRECT CELL KILLING AND IMMUNE STIMULATION VIA MHC CLASS I PRESENTATION AND METHODS REGARDING THE SAME
#64DE-IMMUNIZED SHIGA TOXIN A SUBUNIT EFFECTOR POLYPEPTIDES FOR APPLICATIONS IN MAMMALS
#65Fusion proteins for use as immunogenic enhancers for inducing antigen-specific T cell responses
#66Molecular signature of cancer
#67Fusion protein to target and treat acute myeloid leukemia cells
#68Antibody-drug conjugates and the use of same in therapy
#69Modified forms of exotoxin A
#70Targeting peptides and uses thereof
#71Bivalent IL-2 fusion toxins
#72Method of introducing a toxin or dye into mammalian pluripotent cells using rBC2LCN
#73HIGH LEVEL EXPRESSION OF RECOMBINANT TOXIN PROTEINS
#74Functionalized DNA Dendrimers For Gene Delivery To Cells
#75Modified forms of exotoxin A
#76ANTITUMOUR AGENT, MARKER FOR TUMOUR DETECTION, AND ORAL VACCINE AGENT
#77High-affinity monoclonal antibodies to glypican-3 and use thereof
#78Methods and Compositions for Treating Disease
#79ANTITUMOR PROTOCOL
#80HB-EGF inhibitor derived from the R domain of diphtheria toxin for the treatment of diseases associated with the activation of the HB-EGF/EGFR pathway
#81Immunogenic compositions and reagents for preparing
#82Targeting of chondroitin sulfate glycans
#83Methods and compositions for modulating immune tolerance
#84Fusion proteins for use as immunogenic enhancers for inducing antigen-specific T cell responses
#85Expression system
#86IL3Rα antibody conjugates and uses thereof
#87Methods and compositions for bi-specific targeting of CD19/CD22
#88High level expression of recombinant toxin proteins
#89TREATING CANCER STEM CELLS USING TARGETED CARGO PROTEINS
#90Methods and compositions for modulating immune tolerance
#91Human monoclonal antibodies specific for CD22
#92Methods and Compositions for Treating Disease
#93IL3Rα antibody conjugates and uses thereof
#94Molecular signature of cancer
#95Chimeric protein toxins for expression by therapeutic bacteria